IP Library Granted Patent US 8,257,753
Granted Patent B2
US 8,257,753 · App. 12/724,082 · Granted Sep 4, 2012

Use of an active principle originating from flax in a composition intended to reinforce the barrier function of the skin and to protect the skin and the appendages against external aggressions

Assignee: ISP Investments Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,257,753
App. No.
12/724,082
Granted
Sep 4, 2012
Kind
B2
Abstract

The present invention concerns the use, in a cosmetic composition, of an effective quantity of active principle originating from flax (genus Linum ) to reinforce the barrier function of the skin and to protect the skin and the appendages against external aggressions. The active principle originates from the hydrolysis of flax proteins and contains principally polypeptides or peptides. The invention likewise relates to the use, in a cosmetic composition, of a peptidic hydrolysate of flax as active principle capable of activating HMG-CoA reductase. The invention likewise relates to the use of a peptidic hydrolysate of flax as active principle capable of activating transglutaminase. The active principle can likewise be used to prepare pharmaceutical compositions intended to prevent or combat against the pathologies linked to alterations to the barrier function, such as certain hypersensitivies, irritations of the skin and reactive skins, or atopic dermatitis.

Claims (13)

1. A method of reinforcing barrier function of the skin and stimulating epidermal differentiation of a patient's skin in need thereof, consisting essentially of administering to said patient's skin in need thereof, a cosmetic composition consisting essentially of a therapeutically effective quantity of a hydrolysate from flax seeds that have been hydrolyzed in the presence of polyvinylpolypyrrolidone.

2. The method of claim 1 , wherein said flax seeds have been previously solubilised in one or more solvents selected from the group consisting of water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycol, ethoxylated diglycols, propoxylated diglycols, and cyclic polyols.

3. The method of claim 1 , wherein the hydrolysate from flax seeds are 0.0001% to 20% of the total weight of the composition.

4. The method of claim 1 , wherein the hydrolysate from flax seeds are 0.05% to 5% of the total weight of the composition.

5. A method of reinforcing barrier function of the skin and stimulating epidermal differentiation of a patient's skin in need thereof, consisting essentially of administering to said patient's skin in need thereof, a cosmetic composition consisting essentially of a therapeutically effective quantity of an hydrolysate from flax seeds that have been hydrolyzed in the presence of polyvinylpolypyrrolidone and an active principle selected from the group consisting of vitamin C, vitamin E, the coenzyme Q10, collagen peptide, artemia extract, and combinations thereof.

6. The method of claim 1 , wherein said cosmetic composition is intended to protect the skin and the appendages against all types of external aggressions.

7. The method of claim 6 , wherein said external aggressions are UV radiations.

8. The method of claim 6 , wherein said cosmetic composition improves and repairs skin and the appendages after all types of external aggressions.

9. The method of claim 1 , wherein the hydrolysate from flax seeds has a pH between 5 and 6.

10. The method of claim 1 , wherein the hydrolysate from flax seeds has a dry extract titrated between 2 to 5 g/l.

11. The method of claim 1 , wherein the hydrolysate from flax seeds has between 0.5 and 2 g/l of compounds of peptidic nature.

12. The method of claim 1 , wherein the hydrolysate from flax seeds has a pH between 4 and 7, a dry extract titrated between 1 to 8 g/l, between 0.1 and 5 g/l of compounds of peptidic nature, and between 0.5 to 2.5 g/l of sugars.

13. The method of claim 5 , wherein the cosmetic composition is a sun protection cream.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
SECURITY AGREEMENT Recorded Sep 16, 2011
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; HERCULES INCORPORATED; AQUALON COMPANY; ISP INVESTMENT INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 026918/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2010
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 024270/0976 →
Priority Claims (1)
FR 07 05295 · Jul 20, 2007 · national
Continuity (2)
Continuation In Part 12669836
Related Publication 20100196293A1 · Aug 5, 2010